Clinical Trials on Hypopharyngeal Neoplasms in Canada

Total 7415 results

National Cancer Institute (NCI)

Active, not recruiting

Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin

Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVB Laryngeal Squamous Cell Carcinoma AJCC... and other conditions

United States, Canada
National Cancer Institute (NCI)

Terminated

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage... and other conditions

Canada, United States
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVA Lip and Oral... and other conditions

United States, Canada
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Advanced Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of Unknown Primary | Advanced Hypopharyngeal Squamous Cell Carcinoma | Advanced Laryngeal Squamous Cell Carcinoma | Advanced Oropharyngeal Squamous Cell Carcinoma

United States, Canada
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | Stage... and other conditions

United States, Canada, China
National Cancer Institute (NCI)

Terminated

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in... and other conditions

Canada
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditions

United States, Canada
McGill University Health Centre/Research Institute...

Unknown

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

Colorectal Neoplasm | Liver Neoplasm | Biliary Tract Neoplasm

Canada
Lawson Health Research Institute
London Health Sciences Centre

Completed

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

Malignant Neoplasm

Canada
Lawson Health Research Institute

Completed

Hypertonic Saline 75% vs Mannitol 20%

Brain Tumor | Brain Neoplasm | Tumor, Brain | Neoplasm, Supratentorial | Tumor, Supratentorial

Canada
University of Alberta

Completed

Pre-Operative Single Shot Rectus Sheath Block

Urologic Neoplasms | Pain, Postoperative | Anesthesia, Local | Opioid Use | Prostate Neoplasm | Bladder Neoplasm | Pelvic Neoplasm

Canada
Ottawa Hospital Research Institute
Ottawa Regional Cancer Centre

Completed

Follow-up Care After Treatment for Endometrial Cancer

Endometrial Neoplasm

Canada
University Health Network, Toronto
American Society of Clinical Oncology

Completed

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Liver Neoplasms | Neoplasm Metastases

Canada
Sunnybrook Health Sciences Centre
Genomic Health®, Inc.

Completed

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Hormone Receptor Positive Malignant Neoplasm of Breast

Canada
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Completed

Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes (CT0024)

Neoplasm of Mediastinal Lymph Nodes

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
University Health Network, Toronto

Completed

MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy

Prostate Neoplasm

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Preop Conformal Radiotherapy - Prostate

Prostatic Neoplasm

Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

CT/MRI Co-registration Prostate Cancer

Prostatic Neoplasm

Canada
Sunnybrook Health Sciences Centre
Princess Margaret Hospital, Canada; North York General Hospital

Active, not recruiting

Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization (MOLLI)

Breast Neoplasm

Canada
McMaster University
David Braley and Nancy Gordon Chair in Family Medicine

Unknown

Giving Information on the Risks and Limitations of Mammography Screening (GIRLS) (GIRLS)

Breast Neoplasm

Canada
Juravinski Cancer Center
Canadian Breast Cancer Foundation; Juravinski Cancer Centre Foundation

Unknown

Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer (ARTEMIS)

Breast Neoplasm

Canada
University of Toronto
Canadian Institutes of Health Research (CIHR)

Completed

GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians

Breast Neoplasm

Canada
Hamilton Health Sciences Corporation
Ontario Clinical Oncology Group (OCOG); Juravinski Cancer Centre Foundation

Unknown

Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases (TRICK)

Metastatic Malignant Neoplasm to the Adult Brain

Canada
St. Joseph's Healthcare Hamilton

Completed

The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging

Lung Diseases | Lung Neoplasm

Canada
ATGen Canada Inc

Terminated

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy (ANKA-PCA)

Prostatic Neoplasm | Immunity, Innate

Canada
McMaster University

Active, not recruiting

A Trial Comparing Surgeon-administered TAP Block With Placebo After Midline Laparotomy in Gynecologic Oncology

Surgical Procedure, Unspecified | Genital Neoplasm Malignant Female

Canada
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
Alberta Health services

Completed

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Bone Neoplasms

Canada
St. Joseph's Healthcare Hamilton

Recruiting

Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy

Lung Cancer | Thoracic Cancer | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Sanofi

Completed

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. (IXOGoo1)

Gastric Adenocarcinoma | Gastrointestinal Neoplasm

Canada
Ciusss de L'Est de l'Île de Montréal

Recruiting

Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery (TPVB)

Breast Cancer | Breast Neoplasms | Breast Neoplasm Female | Cancer, Breast

Canada
AHS Cancer Control Alberta

Terminated

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Breast Neoplasm

Canada
St. Joseph's Healthcare Hamilton

Recruiting

Synapse 3D With Intravascular Indocyanine Green

Non-small Cell Lung Cancer | Primary Neoplasm

Canada
Alberta Health services

Unknown

A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer

Neoplasm Metastasis | Rectal Cancer

Canada
Sunnybrook Health Sciences Centre

Unknown

Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

Cancer | Liver Neoplasms | Metastases

Canada
British Columbia Cancer Agency
Ferring Pharmaceuticals

Unknown

Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)

Prostate Neoplasm

Canada
Margie McNeely
Cross Cancer Institute

Completed

Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN) (ULTRA)

Colorectal Neoplasms | Colon Neoplasms

Canada
University of Calgary

Unknown

Microwave Ablation of Primary and Secondary Lung Malignancies

Lung Neoplasms | Neoplasm Metastasis

Canada
University Health Network, Toronto

Active, not recruiting

Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR (PSMA-DOCS)

Neoplasm, Prostate

Canada
University Health Network, Toronto

Completed

Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)

Spinal Metastases

Canada
Sunnybrook Health Sciences Centre

Recruiting

Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors (PDXovo)

Carcinoma, Renal Cell | Metastatic Solid Tumor | Kidney Neoplasm

Canada
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)

Liver Metastases

Canada
University Health Network, Toronto

Completed

Sorafenib-RT Treatment for Liver Metastasis (SLIM)

Cancer | Liver Metastasis

Canada
British Columbia Cancer Agency
National Cancer Institute (NCI)

Completed

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

Cervical Cancer | Precancerous Condition

Canada
British Columbia Cancer Agency
National Cancer Institute (NCI)

Withdrawn

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear

Cervical Cancer | Precancerous Condition

Canada
Philips Healthcare

Completed

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases

Bone Metastasis

Canada
University Health Network, Toronto

Completed

Stereotactic Radiosurgery With Sunitinib for Brain Metastases

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

MSG Use With 18F-DCFPyL PET/CT Imaging

Prostate Cancer | Prostate Cancer Metastatic | Prostatic Neoplasm

Canada
Alberta Health services

Completed

Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix

Cervix Neoplasm

Canada

Clinical Trials on Hypopharyngeal Neoplasms in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations